Rafael Holdings (NYSE:RFL), the parent of Rafael Pharmaceuticals, has announced that Ashok Marin has agreed to join the company’s management team as chief legal officer. Marin will support the company’s quest to become a “fully integrated cancer metabolism therapeutics company,” Rafael Holdings said in a news release. He has previously worked for Gilead, Immunomedics, Mallinckrodt…